The customer would like the run data file investigated to determine a possible cause for the elevated white blood cell (wbc) content in the platelet product.There was not a transfusion recipient or patient involved at the time of the residual wbc testing, therefore no patient information is reasonably known at the time of the event.White blood cell (wbc) count is not available at this time.The platelet collection is not available for return because it was discarded by the customer.This product is not available within the us, but this report is being filed due to an alleged failure that could occur on a similarly marketed device platform cleared for use by the fda.
|
This report is being filed to provide additional information.Initially, the customer reported 7 incidents of elevated white blood cell contaminations.However,during customer follow-up, the customer clarified that a total of 6 white blood cell (wbc)contamination occurred during the months in (b)(6) and (b)(6) 2017.No event occurred for this report, therefore, there is no further information to provide.The 6 incidents of the elevated wbc contamination are reported in mdr#: 1722028-2017-00224,1722028-2017-00225, 1722028-2017-00226, 1722028-2017-00227, 1722028-2017-00228, and 1722028-2017-00229.
|